Put Options

7 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q2 2021

Aug 16, 2021

SELL
$4.17 - $5.74 $62,550 - $86,100
-15,000 Closed
0 $0
Q1 2021

Sep 21, 2023

BUY
$5.28 - $9.64 $79,200 - $144,600
15,000 New
15,000 $79,000
Q1 2021

May 14, 2021

SELL
$5.28 - $9.64 $18,480 - $33,740
-3,500 Reduced 18.92%
15,000 $79,000
Q3 2018

Nov 14, 2018

SELL
$4.75 - $14.5 $459,325 - $1.4 Million
-96,700 Reduced 83.94%
18,500 $88,000
Q2 2018

Aug 14, 2018

BUY
$13.3 - $17.45 $1.53 Million - $2.01 Million
115,200 New
115,200 $1.57 Million
Q1 2018

May 15, 2018

SELL
$14.7 - $24.95 $129,360 - $219,560
-8,800 Closed
0 $0
Q4 2017

Feb 14, 2018

BUY
$19.9 - $29.25 $175,120 - $257,400
8,800
8,800 $204,000

Others Institutions Holding LCI

# of Institutions
1
Shares Held
0
Call Options Held
0
Put Options Held
0

About LANNETT CO INC


  • Ticker LCI
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 42,960,000
  • Market Cap $1.29M
  • Description
  • Lannett Company, Inc. develops, manufactures, packages, markets, and distributes generic versions of brand pharmaceutical products in the United States. The company offers solid oral and extended release, topical, liquid, nasal, and oral solution finished dosage forms of drugs that address a range of therapeutic areas, as well as ophthalmic, nas...
More about LCI
Track This Portfolio

Track Jefferies Group LLC Portfolio

Follow Jefferies Group LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jefferies Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jefferies Group LLC with notifications on news.